HealthThek Applagon Thrombo-Disease Million has announced 7 million

Healthtake ApplaA Helsinki-based clinical stage bioformocial company that developed first-class therapeutic APAC for thrombo-category disease has today announced that it has stopped financing a million dollars millions of dollars. The round of this fund was led by new investors Fahrius…